Medicine and Dentistry
Breast Cancer
100%
Intraductal Carcinoma
31%
Recurrent Disease
23%
Aromatase Inhibitor
20%
Tamoxifen
16%
Neoplasm
15%
Postmenopause
15%
Osteolysis
13%
Cell Activity
10%
Malignant Neoplasm
10%
Estrogen Receptor
9%
Bone Metastasis
9%
Cancer Stem Cell
9%
Programmed Cell Death
9%
Zoledronic Acid
9%
Radiation Therapy
8%
In Vitro
8%
Placebo
8%
Letrozole
7%
Bone Density
7%
Parathyroid Hormone-Related Protein
7%
Exemestane
7%
Cyclooxygenase 2
7%
Tibolone
7%
Epithelial Cell
7%
Angiogenesis
7%
Quadrantectomy
7%
Metastatic Carcinoma
6%
Mastectomy
6%
Prospective Cohort Study
6%
Cancer Therapy
6%
Epidermal Growth Factor Receptor
6%
Biopsy
6%
Hormone Therapy
6%
Meta-Analysis
5%
Adjuvant Therapy
5%
Symptom
5%
Hormone Receptor
5%
Bisphosphonate
5%
Vasculotropin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
45%
Intraductal Carcinoma
25%
Aromatase Inhibitor
16%
Tamoxifen
15%
Neoplasm
12%
Estrogen Receptor
11%
Malignant Neoplasm
10%
Zoledronic Acid
9%
Recurrent Disease
9%
Placebo
8%
Epidermal Growth Factor Receptor
6%
Letrozole
6%
Cyclooxygenase 2
5%
Fulvestrant
5%
Progesterone Receptor
5%
Gefitinib
5%